The World Health Organization has granted permission for emergency use of Moderna COVID-19 vaccine.
The mRNA vaccine from US manufacturers has entered the vaccine from AstraZeneca, Pfizer-BioNTech and Johnson & Johnson in recognition of the WHO’s emergency program.
Similar approvals for the Chinese vaccine Sinopharm and Sinovac are expected in the coming days and weeks, says WHO.
The Moderna vaccine light, which was announced late Friday, took months due to the delay the WHO experienced in getting information from the manufacturer.
Many countries that do not have their own drug testing and evaluation offices rely on the WHO list to decide whether to use the vaccine. UNICEF also uses the site to record vaccinations for emergencies such as epidemics.
The announcement, however, would not affect the Moderna vaccine in the developing world. The company has partnered with several rich countries, which have already received large sums of money.
In a statement Friday, CEO Stephane Bancel said Moderna was “participating in discussions with various organizations, such as COVAX, to protect people around the world.”
He cites a UN-sponsored program to export the COVID-19 vaccine to many low- and middle-income countries, depending on needs.